A detailed history of Boyd Watterson Asset Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Boyd Watterson Asset Management LLC holds 42,420 shares of BMY stock, worth $2.45 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares
42,420
Previous 42,570 0.35%
Holding current value
$2.45 Million
Previous $1.77 Million 24.22%
% of portfolio
0.61%
Previous 0.52%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$39.66 - $51.75 $5,948 - $7,762
-150 Reduced 0.35%
42,420 $2.2 Million
Q2 2024

Aug 14, 2024

SELL
$40.25 - $52.99 $6,238 - $8,213
-155 Reduced 0.36%
42,570 $1.77 Million
Q1 2024

Apr 29, 2024

SELL
$47.98 - $54.4 $37,184 - $42,160
-775 Reduced 1.78%
42,725 $2.32 Million
Q4 2023

Feb 02, 2024

SELL
$48.48 - $57.85 $145,440 - $173,550
-3,000 Reduced 6.45%
43,500 $2.23 Million
Q3 2023

Oct 23, 2023

SELL
$57.89 - $64.73 $175,985 - $196,779
-3,040 Reduced 6.14%
46,500 $2.7 Million
Q4 2022

Jan 18, 2023

SELL
$68.48 - $81.09 $205,440 - $243,270
-3,000 Reduced 5.71%
49,540 $0
Q2 2022

Jul 22, 2022

SELL
$72.62 - $79.98 $279,587 - $307,923
-3,850 Reduced 6.83%
52,540 $4.05 Million
Q1 2022

Apr 27, 2022

BUY
$61.48 - $73.72 $21,518 - $25,802
350 Added 0.62%
56,390 $4.12 Million
Q1 2021

Apr 27, 2021

BUY
$59.34 - $66.74 $8,901 - $10,011
150 Added 0.27%
56,040 $3.54 Million
Q4 2020

Jan 20, 2021

SELL
$57.74 - $65.43 $973,496 - $1.1 Million
-16,860 Reduced 23.18%
55,890 $3.47 Million
Q3 2020

Oct 23, 2020

BUY
$57.43 - $63.64 $4.18 Million - $4.63 Million
72,750 New
72,750 $4.39 Million
Q1 2020

Apr 20, 2020

SELL
$46.4 - $67.43 $157,296 - $228,587
-3,390 Closed
0 $0
Q4 2019

Jan 16, 2020

BUY
$49.21 - $64.19 $166,821 - $217,604
3,390 New
3,390 $218,000
Q2 2019

Jul 24, 2019

SELL
$44.62 - $49.34 $223,590 - $247,242
-5,011 Closed
0 $0
Q1 2019

Apr 09, 2019

BUY
$45.12 - $53.8 $226,096 - $269,591
5,011 New
5,011 $239,000
Q4 2018

Jan 16, 2019

SELL
$48.76 - $63.23 $185,824 - $240,969
-3,811 Closed
0 $0
Q2 2018

Jul 18, 2018

BUY
$50.53 - $62.98 $3,284 - $4,093
65 Added 1.74%
3,811 $211,000
Q1 2018

Apr 19, 2018

SELL
$59.92 - $68.98 $1,797 - $2,069
-30 Reduced 0.79%
3,746 $237,000
Q4 2017

Jan 11, 2018

SELL
$59.94 - $65.35 $2,937 - $3,202
-49 Reduced 1.28%
3,776 $231,000
Q3 2017

Oct 19, 2017

BUY
$55.23 - $63.74 $211,254 - $243,805
3,825
3,825 $244,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Boyd Watterson Asset Management LLC Portfolio

Follow Boyd Watterson Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boyd Watterson Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boyd Watterson Asset Management LLC with notifications on news.